Shares of Elevance Health Inc. ELV slid 1.66% to $421.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

Pharmacists play an indispensable role in the healthcare system across a variety of settings – community pharmacies, primary care facilities, hospitals, health plans, and pharmacy benefit managers ...

Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...

Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...

Elevance Health kicked off 2025 by beating earnings expectations with an EPS of $11.97, flexing its operational muscles ...

Half a dozen of the top industry groups representing car manufacturers and dealers have joined forces in an effort to wave ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Q1 2025 Earnings Call Transcript April 22, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $11.97, ...

Elevance Health Inc. (NYSE: ELV) ended the first quarter of 2025 with better-than-expected financials. The company identified home health as one of its ...

Q1 2025 Management View CEO Gail Boudreaux stated that Elevance Health began 2025 with focus and momentum, highlighting ...

The health insurer posted revenue of $48.89 billion in the period. Its adjusted revenue was $48.77 billion, also topping Street forecasts. Seventeen analysts surveyed by Zacks expected $46.03 billion.